Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Burwell Confirmed As HHS Secretary

This article was originally published in The Gray Sheet

Executive Summary

The Senate approved Sylvia Mathews Burwell as HHS Secretary on a bipartisan vote. The new secretary recently responded to questions on policy issues from the Senate Finance Committee, including on the pending Sunshine Act payment disclosure database and on imaging reimbursement matters.

You may also be interested in...



HHS Appointee Burwell Tells Senate Panel IPAB Will ‘Never Be Activated’

HHS Secretary nominee Sylvia Mathews Burwell told Senate HELP Committee members at her May 8 nomination hearing that the Independent Payment Advisory Board required by the Affordable Care Act will likely “never be activated” because the Obama administration has been able to lower health care costs.

Medicare Advisors Doubt Benefits Of Low-Dose CT For Lung Cancer Screening

A Medicare advisory panel voted “low confidence” on the benefits of low-dose computed tomography for lung cancer screening at an April 30 meeting in Baltimore, Md.

Reimbursement Briefs: PillCam Reimbursement In Japan; 3-D Mammo Code Withdrawn; CMS Data Sharing

Japan will reimburse PillCam COLON. 3-D mammography CPT code application withdrawn from AMA CPT Editorial Panel meeting. CMS unveils new virtual research data-sharing tool.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033053

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel